TrialPanorama/TrialPanorama-database huggingface dataset:
Study 20593354 — Surrogate Endpoint (SUR): Serum creatinine
Study 18372584 — Surrogate Endpoint (SUR): Blood pressure
Study 12824978 — Surrogate Endpoint (SUR): Blood pressure
Study 8891498 — Predictive Biomarker (PRD): C6 mRNA
Genes: C6
Study 31150063 — Predictive Biomarker (PRD): CIT mRNA
Genes: CIT; CRIK; KIAA0949; STK21
Study 30572923 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study 23224336 — Surrogate Endpoint (SUR): Blood pressure
Study 23224336 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 6342359 — Predictive Biomarker (PRD): TNR mRNA
Genes: TNR
Study 31797710 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study 31797710 — Surrogate Endpoint (SUR): Serum creatinine
Study 16390770 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 2668524 — Surrogate Endpoint (SUR): Blood pressure
Study 23683667 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 23683667 — Predictive Biomarker (PRD): CD68 mRNA
Genes: CD68
Study 23683667 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 10899481 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study 8362773 — Surrogate Endpoint (SUR): Blood pressure
Study 8362773 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 30741868 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 30741868 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 28965176 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 26676059 — Surrogate Endpoint (SUR): Blood pressure
Study 20934601 — Predictive Biomarker (PRD): PRF1
Genes: PFP; P1; HPLH2
Study 15800559 — Surrogate Endpoint (SUR): Blood pressure
Study 15800559 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 15800559 — Surrogate Endpoint (SUR): Serum creatinine
Study 12803510 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 12803510 — Surrogate Endpoint (SUR): Serum creatinine
Study 12803510 — Surrogate Endpoint (SUR): Blood pressure
Study 28806366 — Surrogate Endpoint (SUR): Blood pressure
Study 18614724 — Surrogate Endpoint (SUR): Blood pressure
Study 15863986 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 15863986 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 489772 — Surrogate Endpoint (SUR): Blood pressure
Study 21881539 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 21881539 — Predictive Biomarker (PRD): NR1D1 mRNA
Genes: NR1D1; EAR1; HREV; THRAL
Study 21881539 — Predictive Biomarker (PRD): NR1D2 mRNA
Genes: NR1D2
Study 21881539 — Predictive Biomarker (PRD): PER1 mRNA
Genes: PER1; KIAA0482; PER; RIGUI
Study 21881539 — Predictive Biomarker (PRD): BMAL1 mRNA
Genes: BMAL1; ARNTL; BHLHE5; MOP3; PASD3
Study 14980943 — Surrogate Endpoint (SUR): Blood pressure
Study 11686857 — Surrogate Endpoint (SUR): Blood pressure
Study 18614981 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 9010698 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study 9010698 — Surrogate Endpoint (SUR): Blood pressure
Study 31356985 — Safety Biomarker (SAF): BDNF
Study 27812717 — Surrogate Endpoint (SUR): Bone mineral density
Study 22713768 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22713768 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 14522571 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study 14522571 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study 14522571 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 17666472 — Surrogate Endpoint (SUR): Serum calcium
Study 24304551 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26483333 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 23672993 — Predictive Biomarker (PRD): AHR mRNA
Genes: AHR; BHLHE76
Study 18490279 — Surrogate Endpoint (SUR): Blood pressure
Study 19679578 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study 24004887 — Surrogate Endpoint (SUR): Blood pressure
Study 12127125 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 29698772 — Predictive Biomarker (PRD): PRKRA mRNA
Genes: PRKRA; PACT; RAX; HSD-14; HSD14
Study 26111129 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 10738706 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 10738706 — Safety Biomarker (SAF): Eosinophil cationic protein
Genes: RNASE3; ECP; RNS3
Study 10738706 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 8466728 — Surrogate Endpoint (SUR): Blood pressure
Study 3993534 — Surrogate Endpoint (SUR): Blood pressure
Study 20731529 — Pharmacodynamic Biomarker (PDY): Cholesteryl ester transfer protein
Genes: CETP
Study 20731529 — Predictive Biomarker (PRD): PLTP mRNA
Genes: PLTP
Study 20731529 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 20731529 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 8648539 — Surrogate Endpoint (SUR): Blood pressure
Study 1735925 — Surrogate Endpoint (SUR): Serum potassium
Study 20733579 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 30287422 — Surrogate Endpoint (SUR): Blood pressure
Study 22815019 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 25378135 — Predictive Biomarker (PRD); Safety Biomarker (SAF): COX2 mRNA
Genes: PTGS2; COX2
Study 22841520 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22841520 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 22841520 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 22841520 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 22841520 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 16421647 — Surrogate Endpoint (SUR): Bone mineral density
Study 9557074 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 9557074 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study 9557074 — Surrogate Endpoint (SUR): Blood pressure
Study 25532971 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study 17921185 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 17921185 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 9888410 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 1981319 — Surrogate Endpoint (SUR): Blood pressure
Study 23681930 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 3297325 — Surrogate Endpoint (SUR): Blood pressure
Study 11378663 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 25660046 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25660046 — Safety Biomarker (SAF): IL-6 and IL-10
Study 16832714 — Surrogate Endpoint (SUR): Bone mineral density
Study 23238499 — Surrogate Endpoint (SUR): Bone mineral density
Study 20404307 — Predictive Biomarker (PRD): CAPS mRNA
Genes: CAPS
Study 20404307 — Safety Biomarker (SAF): Interleukin 1
Study 21323599 — Surrogate Endpoint (SUR): Bone mineral density
Study 21323599 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 11266374 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study 11266374 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 20192896 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 20192896 — Surrogate Endpoint (SUR): Serum creatinine
Study 10898265 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 26183659 — Surrogate Endpoint (SUR): Blood pressure
Study 7930274 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 17953718 — Surrogate Endpoint (SUR): Serum uric acid
Study 1396254 — Surrogate Endpoint (SUR): Blood pressure
Study 30710885 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30710885 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 9563219 — Surrogate Endpoint (SUR): Blood pressure
Study 18054848 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 25221387 — Surrogate Endpoint (SUR): Blood pressure
Study 22902808 — Monitoring Biomarker (MOI): Cell-free DNA
Study 22902808 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Plasma DNA
Study 10947750 — Surrogate Endpoint (SUR): Blood pressure
Study 6317162 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 31074816 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 24350872 — Surrogate Endpoint (SUR): Blood pressure
Study 19346966 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 19346966 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 17459076 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study 17459076 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 17459076 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 30312183 — Surrogate Endpoint (SUR): Blood pressure
Study 10073742 — Surrogate Endpoint (SUR): Blood pressure
Study 29668401 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study 28719012 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 31391387 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 23788090 — Surrogate Endpoint (SUR): Blood pressure
Study 18834621 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 16634838 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 7949641 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 7949641 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 16951643 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 22293030 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 21400791 — Surrogate Endpoint (SUR): Blood pressure
Study 17591533 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 12196421 — Surrogate Endpoint (SUR): Blood pressure
Study 12196421 — Surrogate Endpoint (SUR): Serum uric acid
Study 12196421 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 9869199 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 9869199 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 365536 — Surrogate Endpoint (SUR): Blood pressure
Study 20559037 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 20559037 — Predictive Biomarker (PRD): TLR9
Genes: CD289
Study 16544524 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 16544524 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 16544524 — Surrogate Endpoint (SUR): Blood pressure
Study 1518257 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 1518257 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study 12605261 — Predictive Biomarker (PRD): ADCY10 mRNA
Genes: ADCY10; SAC
Study 73694 — Surrogate Endpoint (SUR): Blood pressure
Study 31776595 — Surrogate Endpoint (SUR): Blood pressure
Study 28606216 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 19032601 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 11836849 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 11836849 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 11836849 — Safety Biomarker (SAF): Interleukin 1
Study 8053971 — Surrogate Endpoint (SUR): Blood pressure
Study 21473965 — Surrogate Endpoint (SUR): Blood pressure
Study 10866903 — Surrogate Endpoint (SUR): Blood pressure
Study 1325203 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study 1325203 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study 22151106 — Surrogate Endpoint (SUR): Blood pressure
Study 19381108 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 25496265 — Surrogate Endpoint (SUR): Blood pressure
Study 21052689 — Surrogate Endpoint (SUR): Blood pressure
Study 19125892 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 19125892 — Surrogate Endpoint (SUR): Blood pressure
Study 15605872 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study 23436315 — Predictive Biomarker (PRD): CYP2E1 mRNA
Genes: CYP2E1; CYP2E
Study 10619579 — Surrogate Endpoint (SUR): Blood pressure
Study 1721224 — Surrogate Endpoint (SUR): Blood pressure
Study 18711222 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 7843425 — Predictive Biomarker (PRD): ELK3 mRNA
Genes: ELK3; NET; SAP2
Study 17625080 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study 11788633 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 30367542 — Surrogate Endpoint (SUR): Blood pressure
Study 15173716 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 15173716 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 15173716 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 15173716 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 15173716 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 31375874 — Surrogate Endpoint (SUR): Bone mineral density
Study 29045514 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 29045514 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study 21518978 — Surrogate Endpoint (SUR): Blood pressure
Study 16960937 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study 16960937 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study 1584258 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 3882617 — Surrogate Endpoint (SUR): Blood pressure
Study 29276844 — Surrogate Endpoint (SUR): Blood pressure
Study 29276844 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 29150857 — Predictive Biomarker (PRD): LPP mRNA
Genes: LPP
Study 19590588 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 11470017 — Surrogate Endpoint (SUR): Blood pressure
Study 11470017 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 10930195 — Surrogate Endpoint (SUR): Blood pressure
Study 26655398 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 26655398 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 20211108 — Surrogate Endpoint (SUR): Forced vital capacity
Study 11020392 — Surrogate Endpoint (SUR): Bone mineral density
Study 29104158 — Surrogate Endpoint (SUR): Blood pressure
Study 29104158 — Surrogate Endpoint (SUR): Serum creatinine
Study 29104158 — Surrogate Endpoint (SUR): Serum calcium
Study 29104158 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 27636349 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 30838706 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 30880334 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 30880334 — Monitoring Biomarker (MOI): Cell-free DNA
Study 25943183 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 23712686 — Predictive Biomarker (PRD): CPM mRNA
Genes: CPM
Study 19805651 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study 19805651 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 16964557 — Surrogate Endpoint (SUR): Blood pressure
Study 29337835 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 29337835 — Surrogate Endpoint (SUR): Blood pressure
Study 28219442 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study 9662679 — Surrogate Endpoint (SUR): Blood pressure
Study 7877895 — Predictive Biomarker (PRD): GJA1 mRNA
Genes: GJA1; GJAL
Study 7877895 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study 29752398 — Predictive Biomarker (PRD): CAP1 mRNA
Genes: CAP1; CAP
Study 29752398 — Predictive Biomarker (PRD): CAP2 mRNA
Genes: CAP2
Study 19106674 — Predictive Biomarker (PRD): LSR mRNA
Genes: LSR; ILDR3; LISCH
Study 8606536 — Surrogate Endpoint (SUR): Blood pressure
Study 23088223 — Surrogate Endpoint (SUR): Bone mineral density
Study 18036292 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 14972481 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 9627585 — Surrogate Endpoint (SUR): Blood pressure
Study 29515037 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 24035939 — Surrogate Endpoint (SUR): Blood pressure
Study 21242022 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 7740627 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 2258871 — Surrogate Endpoint (SUR): Blood pressure
Study 30528516 — Safety Biomarker (SAF): Interleukin 1
Study 23103498 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 16492208 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 23265033 — Surrogate Endpoint (SUR): Blood pressure
Study 7580831 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 7438679 — Surrogate Endpoint (SUR): Blood pressure
Study 30936377 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study 25787998 — Surrogate Endpoint (SUR): Blood pressure
Study 25787998 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 22289904 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 29102362 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study 31310464 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study 24613817 — Surrogate Endpoint (SUR): Blood pressure
Study 18040531 — Predictive Biomarker (PRD): Carbonic anhydrase IX
Genes: CA9; G250; MN
Study 18040531 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 12079440 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 30390639 — Surrogate Endpoint (SUR): Blood pressure
Study 10736978 — Safety Biomarker (SAF): Antithrombin-III
Genes: SERPINC1; AT3; PRO0309
Study 8859935 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 8859935 — Surrogate Endpoint (SUR): Blood pressure
Study 1509399 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 30403772 — Surrogate Endpoint (SUR): Blood pressure
Study 20929121 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 20929121 — Surrogate Endpoint (SUR): Serum calcium
Study 18037734 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 12384805 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 26712905 — Surrogate Endpoint (SUR): Pathological complete response
Study 20382638 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 15613622 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study 15613622 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study 15613622 — Predictive Biomarker (PRD): ANG mRNA
Genes: ANG; RNASE5
Study 15613622 — Surrogate Endpoint (SUR): Blood pressure
Study 8123485 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 23179351 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 23179351 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 23179351 — Predictive Biomarker (PRD): IL2
Genes: IL-2; TCGF
Study 23179351 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 23179351 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 23179351 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 23179351 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 23179351 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 29389472 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 29389472 — Surrogate Endpoint (SUR): Blood pressure
Study 26998820 — Safety Biomarker (SAF): HLA-DRB1
Genes: HLA-DR1B
Study 20929552 — Predictive Biomarker (PRD): SLMAP mRNA
Genes: SLMAP; KIAA1601; SLAP; UNQ1847/PRO3577
Study 18285698 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study 18285698 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 17086737 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 17086737 — Surrogate Endpoint (SUR): Blood pressure
Study 7937971 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study 8793608 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 29171646 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 23836616 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study 29098260 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 24357015 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study 24357015 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study 20538417 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4